Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Antipsychotic drug dosage and therapeutic response in schizophrenia is influenced by ABCB1 genotypes: a study from a south Indian perspective.

Vijayan NN, Mathew A, Balan S, Natarajan C, Nair CM, Allencherry PM, Banerjee M.

Pharmacogenomics. 2012 Jul;13(10):1119-27. doi: 10.2217/pgs.12.86.

PMID:
22909202
2.

Cytochrome P450 and ABCB1 genetics: association with quetiapine and norquetiapine plasma and cerebrospinal fluid concentrations and with clinical response in patients suffering from schizophrenia. A pilot study.

Nikisch G, Baumann P, Oneda B, Kiessling B, Weisser H, Mathé AA, Yoshitake T, Kehr J, Wiedemann G, Eap CB.

J Psychopharmacol. 2011 Jul;25(7):896-907. doi: 10.1177/0269881110389208. Epub 2010 Dec 8.

PMID:
21148022
3.

ABCB1 polymorphisms are associated with clozapine plasma levels in psychotic patients.

Consoli G, Lastella M, Ciapparelli A, Catena Dell'Osso M, Ciofi L, Guidotti E, Danesi R, Dell'Osso L, Del Tacca M, Di Paolo A.

Pharmacogenomics. 2009 Aug;10(8):1267-76. doi: 10.2217/pgs.09.51.

PMID:
19663671
4.

Polymorphisms of the ABCB1 gene are associated with the therapeutic response to risperidone in Chinese schizophrenia patients.

Xing Q, Gao R, Li H, Feng G, Xu M, Duan S, Meng J, Zhang A, Qin S, He L.

Pharmacogenomics. 2006 Oct;7(7):987-93.

PMID:
17054409
5.

Association study of 27 annotated genes for clozapine pharmacogenetics: validation of preexisting studies and identification of a new candidate gene, ABCB1, for treatment response.

Lee ST, Ryu S, Kim SR, Kim MJ, Kim S, Kim JW, Lee SY, Hong KS.

J Clin Psychopharmacol. 2012 Aug;32(4):441-8. doi: 10.1097/JCP.0b013e31825ac35c.

PMID:
22722500
6.

Intuitive pharmacogenetics: spontaneous risperidone dosage is related to CYP2D6, CYP3A5 and ABCB1 genotypes.

Mas S, Gassò P, Alvarez S, Parellada E, Bernardo M, Lafuente A.

Pharmacogenomics J. 2012 Jun;12(3):255-9. doi: 10.1038/tpj.2010.91. Epub 2010 Dec 21.

PMID:
21173786
7.

Association studies of catechol-O-methyltransferase (COMT) gene with schizophrenia and response to antipsychotic treatment.

Gupta M, Bhatnagar P, Grover S, Kaur H, Baghel R, Bhasin Y, Chauhan C, Verma B, Manduva V, Mukherjee O, Purushottam M, Sharma A, Jain S, Brahmachari SK, Kukreti R.

Pharmacogenomics. 2009 Mar;10(3):385-97. doi: 10.2217/14622416.10.3.385.

PMID:
19290789
8.

Association between ghrelin gene (GHRL) polymorphisms and clinical response to atypical antipsychotic drugs in Han Chinese schizophrenia patients.

Yang Y, Li W, Zhao J, Zhang H, Song X, Xiao B, Yang G, Jiang C, Zhang D, Yue W, Lv L.

Behav Brain Funct. 2012 Feb 28;8:11. doi: 10.1186/1744-9081-8-11.

9.

Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.

Lewis SW, Davies L, Jones PB, Barnes TR, Murray RM, Kerwin R, Taylor D, Hayhurst KP, Markwick A, Lloyd H, Dunn G.

Health Technol Assess. 2006 May;10(17):iii-iv, ix-xi, 1-165.

10.

Acute antipyschotic efficacy and side effects in schizophrenia: association with serotonin transporter promoter genotypes.

Dolzan V, Serretti A, Mandelli L, Koprivsek J, Kastelic M, Plesnicar BK.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Aug 1;32(6):1562-6. doi: 10.1016/j.pnpbp.2008.05.022. Epub 2008 Jun 24.

PMID:
18573584
11.

Use of candidate gene markers to guide antipsychotic dosage adjustment.

Hettige NC, Zai C, Hazra M, Borlido C, Kennedy JL, Strauss J, Le Foll B, Wong A, Remington G, De Luca V.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Oct 3;54:315-20. doi: 10.1016/j.pnpbp.2014.07.001. Epub 2014 Jul 9.

PMID:
25016278
12.

Impact of the ABCB1 gene polymorphism on plasma 9-hydroxyrisperidone and active moiety levels in Japanese patients with schizophrenia.

Suzuki Y, Tsuneyama N, Fukui N, Sugai T, Watanabe J, Ono S, Saito M, Someya T.

J Clin Psychopharmacol. 2013 Jun;33(3):411-4. doi: 10.1097/JCP.0b013e31828ecd52.

PMID:
23609388
13.

Evidence of association of serotonin transporter gene polymorphisms with schizophrenia in a South Indian population.

Vijayan NN, Iwayama Y, Koshy LV, Natarajan C, Nair C, Allencherry PM, Yoshikawa T, Banerjee M.

J Hum Genet. 2009 Sep;54(9):538-42. doi: 10.1038/jhg.2009.76. Epub 2009 Aug 28.

PMID:
19713975
14.

Pharmacogenetics of calcineurin inhibitors in Brazilian renal transplant patients.

Santoro A, Felipe CR, Tedesco-Silva H, Medina-Pestana JO, Struchiner CJ, Ojopi EB, Suarez-Kurtz G.

Pharmacogenomics. 2011 Sep;12(9):1293-303. doi: 10.2217/pgs.11.70. Epub 2011 Aug 1.

PMID:
21806386
15.

Antipsychotic dosage at hospital discharge and outcomes among persons with schizophrenia.

Sohler NL, Walkup J, McAlpine D, Boyer C, Olfson M.

Psychiatr Serv. 2003 Sep;54(9):1258-63.

PMID:
12954943
16.

No association of ABCB1 polymorphisms with drug-refractory epilepsy in a north Indian population.

Lakhan R, Misra UK, Kalita J, Pradhan S, Gogtay NJ, Singh MK, Mittal B.

Epilepsy Behav. 2009 Jan;14(1):78-82. doi: 10.1016/j.yebeh.2008.08.019. Epub 2008 Oct 8.

PMID:
18812236
17.

Influence of CYP3A5 and ABCB1 gene polymorphisms and other factors on tacrolimus dosing in Caucasian liver and kidney transplant patients.

Provenzani A, Notarbartolo M, Labbozzetta M, Poma P, Vizzini G, Salis P, Caccamo C, Bertani T, Palazzo U, Polidori P, Gridelli B, D'Alessandro N.

Int J Mol Med. 2011 Dec;28(6):1093-102. doi: 10.3892/ijmm.2011.794. Epub 2011 Sep 12.

PMID:
21922127
18.

Candidate gene analysis of pharmacodynamic targets for antipsychotic dosage.

Hettige NC, de Moraes GH, Kennedy JL, De Luca V.

Pharmacogenomics. 2016 Feb;17(3):199-208. doi: 10.2217/pgs.15.171. Epub 2016 Jan 18.

PMID:
26780210
19.

Association of ABCB1 gene polymorphisms and their haplotypes with response to antiepileptic drugs: a systematic review and meta-analysis.

Haerian BS, Lim KS, Tan CT, Raymond AA, Mohamed Z.

Pharmacogenomics. 2011 May;12(5):713-25. doi: 10.2217/pgs.10.212. Epub 2011 Mar 11. Review.

PMID:
21391884
20.

Polygenic risk score prediction of antipsychotic dosage in schizophrenia.

Hettige NC, Cole CB, Khalid S, De Luca V.

Schizophr Res. 2016 Feb;170(2-3):265-70. doi: 10.1016/j.schres.2015.12.015. Epub 2016 Jan 8.

PMID:
26778674

Supplemental Content

Support Center